These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 8515654)

  • 1. Treatment of murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonates.
    Sands MS; Barker JE; Vogler C; Levy B; Gwynn B; Galvin N; Sly WS; Birkenmeier E
    Lab Invest; 1993 Jun; 68(6):676-86. PubMed ID: 8515654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal function is improved in a murine model of a lysosomal storage disease following bone marrow transplantation.
    Ohlemiller KK; Vogler CA; Roberts M; Galvin N; Sands MS
    Exp Eye Res; 2000 Nov; 71(5):469-81. PubMed ID: 11040082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In utero fetal liver cell transplantation without toxic irradiation alleviates lysosomal storage in mice with mucopolysaccharidosis type VII.
    Barker JE; Deveau S; Lessard M; Hamblen N; Vogler C; Levy B
    Blood Cells Mol Dis; 2001; 27(5):861-73. PubMed ID: 11783949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain transplantation of genetically modified bone marrow stromal cells corrects CNS pathology and cognitive function in MPS VII mice.
    Sakurai K; Iizuka S; Shen JS; Meng XL; Mori T; Umezawa A; Ohashi T; Eto Y
    Gene Ther; 2004 Oct; 11(19):1475-81. PubMed ID: 15295619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme replacement with recombinant beta-glucuronidase in murine mucopolysaccharidosis type VII: impact of therapy during the first six weeks of life on subsequent lysosomal storage, growth, and survival.
    Vogler C; Sands MS; Levy B; Galvin N; Birkenmeier EH; Sly WS
    Pediatr Res; 1996 Jun; 39(6):1050-4. PubMed ID: 8725268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain transplantation of genetically engineered human neural stem cells globally corrects brain lesions in the mucopolysaccharidosis type VII mouse.
    Meng XL; Shen JS; Ohashi T; Maeda H; Kim SU; Eto Y
    J Neurosci Res; 2003 Oct; 74(2):266-77. PubMed ID: 14515356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow transplantation has a significant effect on enzyme levels and storage of glycosaminoglycans in tissues and in isolated hepatocytes of mucopolysaccharidosis type VII mice.
    Poorthuis BJ; Romme AE; Willemsen R; Wagemaker G
    Pediatr Res; 1994 Aug; 36(2):187-93. PubMed ID: 7970933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine mucopolysaccharidosis type VII: the impact of therapies on the clinical course and pathology in a murine model of lysosomal storage disease.
    Vogler C; Sands MS; Galvin N; Levy B; Thorpe C; Barker J; Sly WS
    J Inherit Metab Dis; 1998 Aug; 21(5):575-86. PubMed ID: 9728337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Widespread biochemical correction of murine mucopolysaccharidosis type VII pathology by liver hydrodynamic plasmid delivery.
    Richard M; Arfi A; Seguin J; Gandolphe C; Scherman D
    Gene Ther; 2009 Jun; 16(6):746-56. PubMed ID: 19357715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syngeneic bone marrow transplantation reduces the hearing loss associated with murine mucopolysaccharidosis type VII.
    Sands MS; Erway LC; Vogler C; Sly WS; Birkenmeier EH
    Blood; 1995 Sep; 86(5):2033-40. PubMed ID: 7655032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme replacement therapy for murine mucopolysaccharidosis type VII.
    Sands MS; Vogler C; Kyle JW; Grubb JH; Levy B; Galvin N; Sly WS; Birkenmeier EH
    J Clin Invest; 1994 Jun; 93(6):2324-31. PubMed ID: 8200966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of systemic clinical disease in MPS VII mice following AAV-mediated neonatal gene transfer.
    Daly TM; Ohlemiller KK; Roberts MS; Vogler CA; Sands MS
    Gene Ther; 2001 Sep; 8(17):1291-8. PubMed ID: 11571565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme replacement in murine mucopolysaccharidosis type VII: neuronal and glial response to beta-glucuronidase requires early initiation of enzyme replacement therapy.
    Vogler C; Levy B; Galvin NJ; Thorpe C; Sands MS; Barker JE; Baty J; Birkenmeier EH; Sly WS
    Pediatr Res; 1999 Jun; 45(6):838-44. PubMed ID: 10367775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine mucopolysaccharidosis type VII: long term therapeutic effects of enzyme replacement and enzyme replacement followed by bone marrow transplantation.
    Sands MS; Vogler C; Torrey A; Levy B; Gwynn B; Grubb J; Sly WS; Birkenmeier EH
    J Clin Invest; 1997 Apr; 99(7):1596-605. PubMed ID: 9120003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathological and behavioral improvement of murine mucopolysaccharidosis type VII by intracerebral transplantation of neural stem cells.
    Fukuhara Y; Li XK; Kitazawa Y; Inagaki M; Matsuoka K; Kosuga M; Kosaki R; Shimazaki T; Endo H; Umezawa A; Okano H; Takahashi T; Okuyama T
    Mol Ther; 2006 Mar; 13(3):548-55. PubMed ID: 16316785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of pathology in murine mucopolysaccharidosis type VII by somatic cell gene transfer.
    Wolfe JH; Sands MS; Barker JE; Gwynn B; Rowe LB; Vogler CA; Birkenmeier EH
    Nature; 1992 Dec 24-31; 360(6406):749-53. PubMed ID: 1465145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene transfer of low levels of beta-glucuronidase corrects hepatic lysosomal storage in a large animal model of mucopolysaccharidosis VII.
    Wolfe JH; Sands MS; Harel N; Weil MA; Parente MK; Polesky AC; Reilly JJ; Hasson C; Weimelt S; Haskins ME
    Mol Ther; 2000 Dec; 2(6):552-61. PubMed ID: 11124056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of a retroviral vector expressing human beta-glucuronidase to the liver and spleen decreases lysosomal storage in mucopolysaccharidosis VII mice.
    Gao C; Sands MS; Haskins ME; Ponder KP
    Mol Ther; 2000 Sep; 2(3):233-44. PubMed ID: 10985954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavior and therapeutic efficacy of beta-glucuronidase-positive mononuclear phagocytes in a murine model of mucopolysaccharidosis type VII.
    Freeman BJ; Roberts MS; Vogler CA; Nicholes A; Hofling AA; Sands MS
    Blood; 1999 Sep; 94(6):2142-50. PubMed ID: 10477745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active site mutant transgene confers tolerance to human beta-glucuronidase without affecting the phenotype of MPS VII mice.
    Sly WS; Vogler C; Grubb JH; Zhou M; Jiang J; Zhou XY; Tomatsu S; Bi Y; Snella EM
    Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2205-10. PubMed ID: 11226217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.